Drug resistance pulmonary tuberculosis in the Eastern Province of Saudi Arabia

Saudi Medical Journal

Volumn 22, Issue 9, 2001, Pages 776-779

  Al Rubaish, Abdullah M ^a   Madania, Ali A ^b   Al Muhanna, Fahd A ^a  

^a IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

^b Al Khobar and the Dammam Chest Hospital   (Saudi Arabia)

Author keywords

Pulmonary tuberculosis; Resistance; Sputum positive

Indexed keywords

ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGE; AGED; ANAMNESIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; GENDER; HEALTH PROGRAM; HEALTH STATUS; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MEDICAL RECORD; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; SAUDI ARABIA; SCREENING TEST; SMEAR; THORAX RADIOGRAPHY; TUBERCULOSIS CONTROL; WORLD HEALTH ORGANIZATION;

EID: 0034766107     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Global epidemiology of tuberculosis: Morbidity and mortality of a worldwide epidemic
2. A review of Tuberculosis in Saudi Arabia
3. High rate of Rifampicin resistance of mycobacterium tuberculosis in the Taif region of Saudi Arabia
4. Resistance to antituberculous drugs in Riyadh, Saudi Arabia
5. Incidence of drug resistance among isolates of Mycobacterium tuberculosis recovered in the Gizan area, Saudi Arabia
6. Molecular mechanism of drug resistance in Mycobacterium tuberculosis
7. Antimicrobial agent resistance in Mycobacteria: Molecular genetic insights
8. Controlled trial of 2, 4 and 6 months of pyrazinamide in 6-month three times weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, Results at 30 months
9. Five-year follow-up of a controlled trial of five 6-months regimens of chemotherapy for pulmonary tuberculosis
10. Primary drug resistance of Mycobacterium tuberculosis to first line anti tubercular agents at Kuwait Chest Disease Hospital during 1992-1995
11. Trends in drug-resistant tuberculosis in the United States 1993-1996
12. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis
13. Drug resistant tuberculosis in sub-Saharan Africa: An estimation of incidence and cost for the year 2000
14. Anti-tuberculosis initial drug resistance of Mycobacterium tuberculosis in Kenya: A ten-year review
15. Nationwide survey of drug-resistant tuberculosis in the United States
16. Primary drug resistance to the major anti-tuberculosis drugs in Japan in 1992
17. Pitfalls in the care of patients with tuberculosis. Common errors and their association with the acquisition of drug resistance
18. Movement of tuberculosis patients and the failure to complete antituberculosis treatment
19. An outbreak of multi-drug resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome
20. Tuberculosis in the 1990s
21. The impact of human immunodeficiency virus infection on drug-resistant tuberculosis
22. Outcome of MDR-TB patients, 1983-1993
23. Treatment of tuberculosis and tuberculosis infection in adults and children
24. The efficacy of varying duration of INH preventive therapy for tuberculosis: Five years follow-up in the I.U.A.T trial